[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568774":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":59,"collaborators":61,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":25,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":25,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":55,"whyStopped":25,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Qilu Hospital of Shandong University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"active stimulation","ACTIVE_COMPARATOR","During the active stimulation condition, participants will receive a single session of tPBM intervention, lasting 12 minutes.",[13],"Device: tPBM（active）",{"label":15,"type":16,"description":17,"interventionNames":18},"sham stimulation","SHAM_COMPARATOR","During the sham stimulation condition, participants will receive the same intervention with identical target areas and wavelength, but only for the first and last 30 seconds of the session.",[19],"Device: tPBM（sham）",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DEVICE","tPBM（active）",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"tPBM（sham）",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Aihua Cao, Post-doctoral","CONTACT","18560086317","xinercah@163.com",[36,54],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"NOT_YET_RECRUITING","Jinan","Shandong","250012","China","CN",{"type":44,"coordinates":45},"Point",[46,47],116.99722,36.66833,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":52,"phoneExt":25,"email":53},"Yongheng Zhao, PhD candidate","15098893217","zyh95817@163.com",{"facility":5,"status":55,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":56,"geoPoint":58,"contacts":25},"RECRUITING",{"type":44,"coordinates":57},[46,47],{"lat":47,"lon":46},{"type":60,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[62,64,66],{"name":63,"class":6},"Capital Medical University",{"name":65,"class":6},"Peking Union Medical College",{"name":67,"class":6},"Chinese Academy of Medical Sciences","100568774","an-intervention-study-on-transcranial-photobiomodulation-in-children-with-attention-deficit-hyperactivity-disorder-100568774",false,"NCT06685601","An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder","An Intervention Study on Transcranial Photobiomodulation for Children With Attention-Deficit\u002FHyperactivity Disorder","Inclusion Criteria:\n\n1. Age between 6 and 18 years;\n2. Clinically diagnosed with ADHD by a psychiatrist;\n3. Confirmed by the researcher (child psychiatrist) to meet the diagnostic criteria for Attention-Deficit\u002FHyperactivity Disorder as outlined in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);\n4. M.I.N.I. KID interview shows only ADHD, with no other comorbidities;\n5. Able to cooperate with transcranial photobiomodulation.\n6. The participant and their guardian fully understand the study procedures and content and agree to participate in the study, signing the informed consent form.\n\nExclusion Criteria:\n\n1. Diagnosis of other severe mental illnesses, such as schizophrenia or bipolar disorder;\n2. Presence of severe physical diseases or conditions, such as significant intracranial lesions, thyroid disorders, epilepsy, congenital heart disease, severe hematologic disorders, systemic lupus erythematosus, auditory or visual impairments, etc.;\n3. Presence of significant structural brain abnormalities on imaging studies;\n4. Presence of severe neurological diseases with a clear family history or potential risk;\n5. Presence of metal implants or a pacemaker, or holes or fractures in the skull;\n6. Currently undergoing other ADHD treatments (e.g., methylphenidate or other pharmacological treatments, behavioral therapy, etc.) or has discontinued such treatments for less than 2 weeks;\n7. Raven's Progressive Matrices IQ score \\\u003C 85.","ALL","6 Years","18 Years",{"count":79,"type":80},60,"ESTIMATED","INTERVENTIONAL",[83],"NA","This study aims to intervene in children and adolescents with ADHD using transcranial photobiomodulation, comparing its effects on executive function at the levels of electroencephalography (EEG), eye tracking, and cognitive behavior. The goal is to identify the most effective clinical treatment strategy for ADHD patients.",[86],"ADHD - Attention Deficit Disorder With Hyperactivity",[88,89],"tPBM","ADHD","2025-07-20",{"date":92,"type":93},"2025-07-22","ACTUAL",{"date":95,"type":93},"2024-12-16",{"date":97,"type":80},"2027-05",{"name":5,"class":6},2]